Squarepoint Ops LLC Enochian Biosciences Inc Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	14,765 New	14,765 $67,000
Q2 2022 Aug 15, 2022	SELL	$1.93 - $8.73 $25,209 - $114,031	-13,062 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $57,734 - $117,558	13,062 New	13,062 $108,000
Q1 2021 May 17, 2021	SELL	$3.02 - $4.51 $61,928 - $92,482	-20,506 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $31,868 - $40,118	-11,301 Reduced 35.53%	20,506 $60,000
Q3 2020 Nov 16, 2020	BUY	$3.42 - $4.55 $108,779 - $144,721	31,807 New	31,807 $114,000
Q4 2019 Feb 14, 2020	SELL	$3.48 - $6.75 $35,294 - $68,458	-10,142 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.95 - $5.72 $23,597 - $34,171	-5,974 Reduced 37.07%	10,142 $56,000
Q2 2019 Aug 14, 2019	BUY	$4.5 - $6.99 $72,522 - $112,650	16,116 New	16,116 $73,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.